期刊文献+

从药物信息学角度研究药物协同性的研究进展 被引量:1

Research Progress on the Synergistic Effect of Drug Combination from the Perspective of Pharmacoinformatics
原文传递
导出
摘要 目前临床上很多单一药物的使用已经不能满足复杂疾病的治疗需求,而多药物的联合使用,往往可以增强药效或者降低药物的不良反应,从而体现药物联用的协同性优势。因此药物协同性研究不论对于新药创制还是临床治疗方案的优化均具有积极的意义。相对于传统的实验手段,应用药物信息学方法研究药物的协同性,具有“快速、低成本、绿色”的优势。本文从药物信息学的角度对相关的资源数据库(包括药物及疾病的相关信息)、不同的预测模型以及应用情况进行详细描述,从而为开发新的分析模型提供参考。 The use of single-agent no longer meets the requirements of complex disease treatment in current clinical practice.The combination of multiple drugs can often enhance the efficacy or reduce the adverse reaction of drugs,thus reflecting the synergistic advantages of drug combination.Therefore,the investigation of drug synergy is meaningful for the new drug discovery as well as the optimization of clinical treatment programme.Compared with the traditional experimental methods,pharmacoinformatics is a promising way to identify the synergistic effect of drug combination because of its fast,lower-cost,and green characteristics.This article reviews the advances in the databases that include the information of drug and disease,computational models and applications of the synergistic effect of drug combination from the perspective of pharmacoinformatics approaches,so as to provide reference for the development of new analysis models for drug synergy.
作者 陈倩倩 李雪 陈石秀 鹿振辉 郑培永 杨铭 CHEN Qianqian;LI Xue;CHEN Shixiu;LU Zhenhui;ZHENG Peiyong;YANG Ming(Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)
出处 《中国现代应用药学》 CAS CSCD 北大核心 2020年第24期3051-3056,共6页 Chinese Journal of Modern Applied Pharmacy
基金 “重大新药创制”国家科技重大专项(2017ZX09304001) 国家十三五传染病防治科技重大专项(2017ZX10305501-002) 上海市科学技术委员会科研计划项目(18495810600) 上海中医药大学预算内科研项目(18LK036)。
关键词 药物信息学 药物协同性效应 资源数据库 预测模型 pharmacoinformatics synergistic effect of drug combination information databases computational models
  • 相关文献

参考文献2

二级参考文献23

  • 1方开泰.均匀设计及其应用[J].数理统计与管理,1994,13(1):57-63. 被引量:131
  • 21,Elkind AH.Drug abuse andheadache.Medical Clinics of North America,1991,75(3)∶727.
  • 32,Fialip J,Porteix A,Marty H,et alLack of importance of caffeine as an analgesicadjuvant of dipyine in mice.Arch Int Pharmacodyn Ther,1989,302∶86.
  • 47,Zheng QS,Sun RY.Analysis of multidrug effects by parameter method.Acta PharmacologSin,1998,19(3)∶232.
  • 58,曾雪玉,洪庚辛.见:陈奇主编.中药药理研究方法学.北京:人民卫生出版社,1993∶380.
  • 69,杨秀英,李淑仪.见:陈奇主编.中药药理研究方法学.北京:人民卫生出版社,1993∶667.
  • 7Swain SM, Whaley FS, Ewer MS. Congestive heart failure in pa- tients treated with doxombicin : a retrospectiveanalysis of three trials [J]. Cancer, 2003,97( 11 ) :2869-2879.
  • 8Childs AC, Phaneuf SL, Dirks AJ, et al. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase ac- tivity, and Bcl-2 :Bax ratio [ J ]. Cancer Res, 2002,62 ( 16 ) : 4592-4598.
  • 9Chularojmontri L, Gerdprasert O, Wattanapitayakul SK. Pummelo protects doxorubicin-induced cardiac cell death by reducing oxidative stress, modifying glutathione transferase expression, and preventing cellular senescence [ J ]. Evid Based Complement Alternat Med, 2013 (2013 ) :254835.
  • 10Hatcher H, Planalp R, Cho J, et al. Curcumin: From ancient med- icine to current clinical trials [ J ]. Cell Mol Life Sci, 2008,65 (11) :1631-1652.

共引文献9

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部